Gaurav Shah - 14 May 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: CEO, Director
Signature: /s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol: RCKT
Transactions as of: 14 May 2023
Net transactions value: $0
Form type: 4
Filing time: 16 May 2023, 20:04:37 UTC
Previous filing: 22 Feb 2023
Next filing: 19 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Options Exercise	$0	+7,979	+1.5%	$0.000000	525,764	14 May 2023	Direct	F1
holding	RCKT	Common Stock						207,897	14 May 2023	By Spouse
holding	RCKT	Common Stock						198,341	14 May 2023	By Gaurav D. Shah Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCKT	Restricted Stock Units	Options Exercise	$0	-7,979	-12%	$0.000000	55,856	14 May 2023	Common Stock	7,979		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.
F2	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3	One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.